Effects of Presenilin 1 Mutations on β-Catenin Signaling
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
April 01, 2002 - March 31, 2004
Grant ID
A2002035
Summary
The death of neurons in the brain is a symptom of Alzheimer’s disease (AD) that is believed to be a major factor in the cognitive impairment affecting Alzheimer’s patients. The death of neurons may result from the accumulation of plaques between neurons as well as from the formation of neurofibrillary tangles within neurons. However, why these factors are toxic is not known. One theory is that the high-stress environment found in AD can trigger neurons into starting cell division, but the cells lack the appropriate components to divide and, as a consequence, the process results in cell death. Dr. Tyan will focus on the early-onset form of familial AD that is linked to mutations in the presenilin proteins (PS). She proposes that PS1 deficiency and PS1 mutations upregulate β-catenin signaling in the adult brain. This leads to increased levels of the cyclin D1, which is a component used by neurons in their attempt to start dividing in response to environmental challenge. The high levels of cyclin D1 are thought to contribute to abnormal cell division and cell cycle signaling, resulting in the neuronal loss seen in AD. Dr. Tyan is studying transgenic animals to determine whether β-catenin signaling through cyclin D1 and abnormal cell divisions occur in the neurons of animals with AD. Understanding what causes neuronal cell death will help in designing treatments to prevent neuronal death or delay it sufficiently to improve the quality of life for Alzheimer’s patients.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University